Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.

about

Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.

Item

http://www.wikidata.org/entity/Q47428473

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.

@en

Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.

@nl

type

Item

label

Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.

@en

Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.

@nl

prefLabel

Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.

@en

Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.

@nl

P1476

Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1

@en

P2093

Alex G Papageorge

http://www.w3.org/2001/XMLSchema#string

Brajendra K Tripathi

http://www.w3.org/2001/XMLSchema#string

Dunrui Wang

http://www.w3.org/2001/XMLSchema#string

Ming Zhou

http://www.w3.org/2001/XMLSchema#string

Philipp Mertins

http://www.w3.org/2001/XMLSchema#string

Steven A Carr

http://www.w3.org/2001/XMLSchema#string

Xiaolan Qian

http://www.w3.org/2001/XMLSchema#string

P2860

DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development

DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms

The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1

The 'invisible hand': regulation of RHO GTPases by RHOGDIs

Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities

Targeting CDK4/6 in patients with cancer

The RhoA-ROCK pathway in the regulation of T and B cell responses

Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)

Rho Kinases in Health and Disease: From Basic Science to Translational Research

Identification of p122RhoGAP (deleted in liver cancer-1) Serine 322 as a substrate for protein kinase B and ribosomal S6 kinase in insulin-stimulated cells

P304

4255-4270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.201703105

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

216

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29114068

http://www.w3.org/2001/XMLSchema#string

P932

5716279

http://www.w3.org/2001/XMLSchema#string